Product Detail
Zonisamide-d4
Zonisamide Stable Isotopes
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Zonisamide
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Zonisamide-d4 Product Information
Zonisamide-d4 is listed under Stable Isotopes. It is associated with Zonisamide and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-02921.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Zonisamide-d4
CAS No.
1020720-04-0
CAT No.
CS-O-02921
Molecular Formula
C8H4D4N2O3S
Molecular Weight
216.25
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
C(S(N)(=O)=O)C=1C=2C(ON1)=C(C(=C(C2[2H])[2H])[2H])[2H]
IUPAC Name
Benzo[d]isoxazol-3-ylmethanesulfonamide-D4
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Labelled sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation f;Labeled Zonisamide, intended for use as an internal standard for the quantification of Zonisamide by GC- or LC-mass spectrometry."
Synonyms
(Benzo[d]isoxazol-3-yl-d4)methanesulfonamide
Application Notes
"Labelled sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation f;Labeled Zonisamide, intended for use as an internal standard for the quantification of Zonisamide by GC- or LC-mass spectrometry."
References
"Masuda; Y,; et al,: Arzneim,-Forsch,; 30; 477 (1980); Hammond; E,J,; et al,: Gen, Pharmacol,; 18; 303 (1987); Schmidt; D,; et al,: Epilepsy Res,; 15; 67 (1993); Sorkin; E,M,; et al,: Drugs; 45; 760 (1993);"
